相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures
Harald Loppnow et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The Sterile Inflammatory Response
Kenneth L. Rock et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Comparison of gene expression profiles between human and mouse monocyte subsets
Molly A. Ingersoll et al.
BLOOD (2010)
Sensing Cytoplasmic Danger Signals by the Inflammasome
Emad S. Alnemri
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
Satoshi Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Monocytes in atherosclerosis: subsets and functions
Kevin J. Woollard et al.
NATURE REVIEWS CARDIOLOGY (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Jurg Tschopp et al.
NATURE REVIEWS IMMUNOLOGY (2010)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Functional Role of CD11c+ Monocytes in Atherogenesis Associated With Hypercholesterolemia
Huaizhu Wu et al.
CIRCULATION (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
Stefan Rose-John et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14(+)CD16(+) monocytes in detoxification of oxidized LDL
Sandy Mosig et al.
FASEB JOURNAL (2009)
Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
Mari A. Nowell et al.
JOURNAL OF IMMUNOLOGY (2009)
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
Satoshi Suzuki et al.
AMERICAN HEART JOURNAL (2008)
Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans
Yutaka Nakashima et al.
CARDIOVASCULAR RESEARCH (2008)
Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Harald Loppnow et al.
INNATE IMMUNITY (2008)
Rod-Shaped Monocytes Patrol the Brain Vasculature and Give Rise to Perivascular Macrophages under the Influence of Proinflammatory Cytokines and Angiopoietin-2
Julie Audoy-Remus et al.
JOURNAL OF NEUROSCIENCE (2008)
Actemra poised to launch IL-6 inhibitors
Lisa Melton et al.
NATURE BIOTECHNOLOGY (2008)
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Bjorn Rabe et al.
BLOOD (2008)
Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3
Alberto Mantovani et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation - Synergism of TLR2 and TLR4
Masakazu Shinohara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Differential role and tissue specificity of interleukin-1α gene expression in atherogenesis and lipid metabolism
Yehuda Kamari et al.
ATHEROSCLEROSIS (2007)
A new class of reverse signaling costimulators belongs to the TNF family
Mingyi Sun et al.
JOURNAL OF IMMUNOLOGY (2007)
Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils
Athena Chalaris et al.
BLOOD (2007)
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
Maren Luchtefeld et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior
Cedric Auffray et al.
SCIENCE (2007)
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo
Barbara Coles et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Mast cells promote atherosclerosis by releasing proinflammatory cytokines
Jiusong Sun et al.
NATURE MEDICINE (2007)
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
Stefan Rose-John et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Decreased atherosclerosis in mice deficient in tumor necrosis factor-alpha receptor-II (p75)
Unni M. Chandrasekharan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1 alpha
Elena Westphal et al.
JOURNAL OF ENDOTOXIN RESEARCH (2007)
Inflammatory biomarkers in stable atherosclerosis
Scott Kinlay et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways
Feng-Yen Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Critical role of inducible costimulator signaling in the development of arteriosclerosis
Hisanori Kosuge et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Nod-like proteins in immunity, inflammation and disease
Jorg H. Fritz et al.
NATURE IMMUNOLOGY (2006)
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
K. Mitsuyama et al.
GUT (2006)
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer
Stefan Rose-John et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6
N Takeda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Cytokines in atherosclerosis: Pathogenic and regulatory pathways
A Tedgui et al.
PHYSIOLOGICAL REVIEWS (2006)
Interleukin-1β and signaling of interleukin-1 in vascular wail and circulating cells modulates the extent of neointima formation in mice
J Chamberlain et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Mechanisms of disease: atherosclerosis in autoimmune diseases
Y Sherer et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The evolution of vertebrate Toll-like receptors
JC Roach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice
F Merhi-Soussi et al.
CARDIOVASCULAR RESEARCH (2005)
Disruption of tumor necrosis factor-α gene diminishes the development of atherosclerosis in ApoE-deficient mice
H Ohta et al.
ATHEROSCLEROSIS (2005)
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
H Björkbacka et al.
NATURE MEDICINE (2004)
C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
A Paul et al.
CIRCULATION (2004)
Mechanism of lipoprotein retention extracellular matrix
M Gustafsson et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model - Pharmacotherapeutic implications
HH Chi et al.
CIRCULATION (2004)
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques
J Llodrá et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis
B Schieffer et al.
CIRCULATION (2004)
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
S Watanabe et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury
K Isoda et al.
CIRCULATION (2003)
Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization
ZB Wang et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice
H Kirii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Vascular smooth muscle cell activation by C-reactive protein
Y Hattori et al.
CARDIOVASCULAR RESEARCH (2003)
Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-κB and activator protein-1
C Viedt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size
CM Devlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL
XH Xu et al.
CIRCULATION (2001)
Soluble interleukin-6 receptor a inhibits the cytokine-induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture
T Matsumiya et al.
EXPERIMENTAL CELL RESEARCH (2001)
Smooth muscle cells influence monocyte response to LDL as well as their adhesion and transmigration in a coculture model of the arterial wall
F Kinard et al.
JOURNAL OF VASCULAR RESEARCH (2001)
Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease
HJ Rupprecht et al.
CIRCULATION (2001)
IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation
SM Hurst et al.
IMMUNITY (2001)
Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice
R Elhage et al.
ATHEROSCLEROSIS (2001)
Chronic infections and the risk of carotid atherosclerosis - Prospective results from a large population study
S Kiechl et al.
CIRCULATION (2001)
Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins
K Althoff et al.
BIOCHEMICAL JOURNAL (2001)
Cytokines: Classification, receptors and action mechanisms
H Loppnow
INTERNIST (2001)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Interaction between monocytes and vascular smooth muscle cells induces expression of hepatocyte growth factor
M Okada et al.
JOURNAL OF HYPERTENSION (2000)
Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production
Y Zhu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells
Y Hojo et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
Interaction between human monocytes and vascular smooth muscle cells induces vascular endothelial growth factor expression
Y Hojo et al.
ATHEROSCLEROSIS (2000)
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques - Potential implications for inflammation and plaque instability
B Schieffer et al.
CIRCULATION (2000)